5 terminated, 2 completed. 5 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Terminated 3, Completed 2 |
| Phase 3 | 2 | Terminated 2 |
| Phase 1 | 1 | Completed 1 |
Follow birtamimab: new trials by email Literature Review of birtamimab trials Research Report on birtamimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of Birtamimab in Mayo Stage IV Patients With AL Amyloidosis Birtamimab, Placebo, Standard of Care Chemotherapy - Light Chain (AL) Amyloidosis | Phase 3 | Terminated | Prothena Biosciences Ltd. | 208 | 2021-08-30 | 2025-12-16 |
| Renal AL Amyloid Involvement and NEOD001 NEOD001, Placebo - Amyloidosis | Phase 2 | Terminated | Tufts Medical Center | 12 | 2017-07-05 | 2020-09-09 |
| Study in Subjects With Light Chain (AL) Amyloidosis NEOD001 - AL Amyloidosis | Phase 2 | Terminated | Prothena Biosciences Ltd. | 80 | 2017-06-14 | 2019-03-26 |
| The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis NEOD001, Placebo - AL Amyloidosis | Phase 2 | Completed | Prothena Biosciences Ltd. | 129 | 2016-03-01 | 2019-04-05 |
| Open-label Extension Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis NEOD001 - AL Amyloidosis | Phase 2 | Terminated | Prothena Biosciences Ltd. | 34 | 2016-02-01 | 2019-05-16 |
| The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis NEOD001, Placebo - Primary Systemic (AL) Amyloidosis | Phase 3 | Terminated | Prothena Biosciences Ltd. | 260 | 2015-02-01 | 2023-11-14 |
| Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis NEOD001 - Primary Amyloidosis | Phase 1 / Phase 2 | Completed | Prothena Biosciences Ltd. | 69 | 2013-04-01 | 2018-08-28 |
Immunoglobulin Light-chain Amyloidosis (5) · Amyloidosis (3) · Alzheimer Disease (1) · Paraproteinemias (1)
Prothena Biosciences Ltd. (6) · Tufts Medical Center (1)
United States (7) · Australia (4) · Austria (4) · France (4) · Germany (4) · Greece (4) · Israel (4) · Italy (4) · Spain (4) · United Kingdom (4) · Belgium (2) · Canada (2) · Denmark (2) · Netherlands (2) · Poland (2)
Julia Martinisi (1) · Raymond Comenzo, MD (1)